WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003002568) CARBOHYDRATE DERIVATIVES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/002568    International Application No.:    PCT/EP2002/005891
Publication Date: 09.01.2003 International Filing Date: 29.05.2002
Chapter 2 Demand Filed:    19.12.2002    
IPC:
C07D 493/04 (2006.01)
Applicants: MERCK PATENT GMBH [DE/DE]; Frankfurter Str. 250, 64293 Darmstadt (DE) (For All Designated States Except US).
RADDATZ, Peter [DE/DE]; (DE) (For US Only).
DORSCH, Dieter [DE/DE]; (DE) (For US Only).
GLEITZ, Johannes [DE/DE]; (DE) (For US Only).
BARNES, Christopher [GB/DE]; (DE) (For US Only).
KOERT, Ulrich [DE/DE]; (DE) (For US Only).
VOLGER, Marko [DE/DE]; (DE) (For US Only)
Inventors: RADDATZ, Peter; (DE).
DORSCH, Dieter; (DE).
GLEITZ, Johannes; (DE).
BARNES, Christopher; (DE).
KOERT, Ulrich; (DE).
VOLGER, Marko; (DE)
Common
Representative:
MERCK PATENT GMBH; Frankfurter Str. 250, 64293 Darmstadt (DE)
Priority Data:
101 30 718.7 26.06.2001 DE
Title (DE) KOHLENHYDRATDERIVATE
(EN) CARBOHYDRATE DERIVATIVES
(FR) DERIVES D'HYDRATES DE CARBONE
Abstract: front page image
(DE)Neue Verbindungen der Formel 1 worin Y, T, W, R1 und R2 die in Patentanspruch (1) angegebene Bedeutung haven, sind Inhibitoren des Koagulationsfaktors Xa und können zur Prophylaxe und/oder Therapie von thromboembolischen Erkrankungen und zur Behandlung von Tumoren eingesetzt werden.
(EN)The invention relates to the novel compounds of formula (I), wherein Y, T, W, R1 and R2 are defined as in claim 1. The inventive compounds are inhibitors of coagulation factor Xa and are used in the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors.
(FR)L'invention concerne de nouveaux composés de formule I dans laquelle Y, T, W, R1 et R2 sont tels que définis dans la première revendication. Ces nouveaux composés sont des inhibiteurs du facteur de coagulation Xa et peuvent être employés pour prévenir et/ou traiter des maladies thromboemboliques et pour traiter des tumeurs.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)